Irinotecan sucrosofate companion diagnostic (Merrimack Pharmaceuticals)

N/A

Report date: 2025/03/13 15:11:02

Base Information

Drug NameIrinotecan sucrosofate companion diagnostic (Merrimack Pharmaceuticals)
Drug Alias NameFerumoxytol (Merrimack Pharmaceuticals)MM-398 companion diagnostic
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerrimack Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerrimack Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A